VEGFA could stimulate EMT of pancreatic neuroendocrine tumour cells in vitro.38 In breast cancer, VEGFA led to EMT by up‐regulating SOX2 expression in vivo and in vitro. The gene discussed is VEGFA; the disease is breast cancer.